Comparison of the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer according to the Type of Epidermal Growth Factor Receptor Mutation.

MLA

Igawa, Satoshi, et al. “Comparison of the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer According to the Type of Epidermal Growth Factor Receptor Mutation.” Oncology, vol. 87, no. 4, Sept. 2014, pp. 215–23. EBSCOhost, https://doi.org/10.1159/000362603.

APA

Igawa, S., Kasajima, M., Ishihara, M., Kimura, M., Hiyoshi, Y., Asakuma, M., Otani, S., Katono, K., Sasaki, J., & Masuda, N. (2014). Comparison of the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer according to the Type of Epidermal Growth Factor Receptor Mutation. Oncology, 87(4), 215–223. https://doi.org/10.1159/000362603

Chicago

Igawa, Satoshi, Masashi Kasajima, Mikiko Ishihara, Michiko Kimura, Yasuhiro Hiyoshi, Maiko Asakuma, Sakiko Otani, Ken Katono, Jiichiro Sasaki, and Noriyuki Masuda. 2014. “Comparison of the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer According to the Type of Epidermal Growth Factor Receptor Mutation.” Oncology 87 (4): 215–23. doi:10.1159/000362603.